Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Vascular Malformations 1Unresectable Locally Advanced or Metastatic Solid Tumors 1Triple Negative Breast Neoplasms 1Skin Neoplasms 1Phase IB 1Nevus 1Neoplasms, Plasma Cell 1Lymphoma 1Lymphangioma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hemangioma 1Hemangioendothelioma 1Hamartoma Syndrome, Multiple 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Bone Neoplasms 1Autistic Disorder 1Arteriovenous Malformations 1

Interventions

Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Hamartoma Syndrome, Multiple × Everolimus × Clear all
NCT07218575 2026-06-04

Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations

Boston Children's Hospital

Phase 2/3 Not yet recruiting
60 enrolled

Autistic Disorder, Hamartoma Syndrome, Multiple

Data powered by HemOnc (CC BY 4.0) Colophon âš¡